Our active medical ingredients are a type of appetite suppressant and mimic the hormone GLP-1, which is normally released in the intestine to create a feeling of satiety after a meal
Managing blood sugar is critical as type 2 diabetes rates rise globally
Weight loss achievable with medical therapy is becoming closer to that seen with bariatric surgery in people with T2D and obesity, potentially making sustained, substantial weight loss achievable for a greater proportion of these individuals
The pharmacokinetics of low-dose tirzepatide Tirzepatide has a half-life of approximately five days, which supports once-weekly dosing
The Scottish Medicines Consortium (SMC) reviews medicines for NHS Scotland, the All Wales Medicines Strategy Group (AWMSG) for NHS Wales, and the Department of Health for Northern Ireland
This effect can occur in a case of quick standing after an injection